M3, Inc. 2413.T · Stock Open M3, Inc. in new tab
M3, Inc. Analysis (2413.T)
Is M3, Inc. a good investment? M3, Inc. (2413.T) is currently trading at 1894.00 JPY. Market analysts have a consensus price target of 2162.50 JPY. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 25.01. This valuation is generally in line with the broader market.
Earnings Schedule: M3, Inc. is expected to release its next earnings report on July 29, 2026. The market consensus estimate for Forward EPS is 71.65.
For income investors, M3, Inc. pays a dividend yield of 1.21%. With a payout ratio of 30%, the dividend appears sustainable.
Investor FAQ
Does M3, Inc. pay a dividend?
Yes, it pays an annual dividend of 22.00 JPY (1.21% yield).
What asset class is M3, Inc.?
M3, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be July 29, 2026. The company currently has a trailing EPS of 72.46.
Company Profile
M3, Inc. provides medical-related services to physicians and other healthcare professionals through the internet. It operates m3.com, a members-only website for providing information, tools, and services for medical professionals; MR-kun which delivers the latest medical information for daily medical practice; QOL-kun, a marketing support service that provides selected information useful for doctors; m3.com CAREER, a physician recruitment and career change support site; and Yakucari, a job search website for pharmacists. The company also provides online lectures; clinical trial; research targeting domestic medical professionals; medical-related self-planned data and research reports; global health professional research; survey panel provision services; and m3.com opening and management services. In addition, it offers AskDoctors, where registered doctors answer questions about health and illness from the public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides services for pharmaceutical companies; and drug information database. Further, the company is involved in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; Support for recruiting subjects necessary for clinical development and clinical research, and related tasks; provision of management support to medical institutions, as well as visiting nursing, day care, and home care support services; and operates podiatry and venous disease clinics, and hospice facilities. Additionally, it offers clinical and medico-political news and education for medical professionals. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
| Year | Total Dividends |
|---|---|
| ▸2027 |
27.71 JPY
|
| June 14, 2027 (estimated) | 27.7082 |
| ▸2026 |
22.00 JPY
|
| June 12, 2026 | 22.0000 |
| ▸2025 |
21.00 JPY
|
| June 9, 2025 | 21.0000 |
| ▸2024 |
21.00 JPY
|
| June 10, 2024 | 21.0000 |
| ▸2023 |
19.00 JPY
|
| June 12, 2023 | 19.0000 |
| ▸2022 |
16.00 JPY
|
| June 13, 2022 | 16.0000 |
| ▸2021 |
12.00 JPY
|
| June 10, 2021 | 12.0000 |
| ▸2020 |
8.50 JPY
|
| June 16, 2020 | 8.5000 |
| ▸2018 |
11.00 JPY
|
| June 8, 2018 | 11.0000 |
| ▸2017 |
10.00 JPY
|
| June 12, 2017 | 10.0000 |
| ▸2016 |
9.00 JPY
|
| March 29, 2016 | 9.0000 |
| ▸2015 |
8.00 JPY
|
| March 27, 2015 | 8.0000 |
| ▸2014 |
1,300.00 JPY
|
| March 27, 2014 | 1,300.0000 |
| ▸2012 |
2,500.00 JPY
|
| March 28, 2012 | 2,499.9996 |
| ▸2011 |
1,100.00 JPY
|
| March 29, 2011 | 1,099.9992 |
| ▸2010 |
3,600.00 JPY
|
| March 29, 2010 | 3,600.0000 |
| ▸2009 |
3,300.00 JPY
|
| March 26, 2009 | 3,300.0000 |
| ▸2008 |
3,000.00 JPY
|
| March 26, 2008 | 3,000.0000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| M3, Inc. | Jun 12, 2026 | Paid | 22.0 JPY |
Community Discussion